Literature DB >> 10073318

Pharmacologic therapy for asthma: overview and historical perspective.

D W Cockcroft1.   

Abstract

For the 30 years between 1967 and 1997, pharmacologic therapy of asthma has consisted primarily of five classes of drugs, beta 2-agonists, anticholinergics, theophyllines, cromones, and corticosteroids. The first four of these classes of drugs have origins in herbal treatments going back 5000 or 6000 years. This article briefly reviews the history of asthma pharmacotherapy up to the late 1990s and outlines a current approach to the pharmacotherapy of asthma, which is but one component of an integrated overall approach to asthma treatment involving patient education and environmental control as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073318

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

1.  A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.

Authors:  Yukiko Hori; Shuko Takeda; Hansang Cho; Susanne Wegmann; Timothy M Shoup; Kazue Takahashi; Daniel Irimia; David R Elmaleh; Bradley T Hyman; Eloise Hudry
Journal:  J Biol Chem       Date:  2014-12-02       Impact factor: 5.157

Review 2.  Clinical concerns with inhaled beta2-agonists: adult asthma.

Authors:  D W Cockcroft
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 3.  Beta2-agonists and bronchial hyperresponsiveness.

Authors:  Clive P Page; Domenico Spina
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

4.  Asthma and therapeutics: recombinant therapies in asthma.

Authors:  Donald W Cockcroft
Journal:  Allergy Asthma Clin Immunol       Date:  2005-03-15       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.